Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products. This segment also provides the ASCENDrive programs; SURPASS Performance Group services; SaaS informatics products; supply chain co-management services; and supply chain resiliency programs, as well as digital invoicing and payables services. Its Performance Services segment provides a technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care. Premier, Inc. was incorporated in 2013 and is headquartered in Charlotte, North Carolina. As of November 25, 2025, Premier, Inc. was taken private.
Supply Chain Triumph | Premier's Supply Chain Services segment outperforms expectations, driving significant revenue and EBITDA growth in Q3 FY2025 |
Margin Mastery | Explore Premier's impressive 9 percentage point gross margin beat, raising questions about sustainability and long-term growth potential |
Strategic Renewals | Delve into the impact of Premier's August 2020 restructure cohort renewals on customer relationships and revenue streams |
Cautious Optimism | Analysts target $24.00 price range amid raised EBITDA guidance, balanced against concerns over purchasing volume sustainability |
Metrics to compare | PINC | Peers Peers - average of corresponding metrics from companies closely matching PINC: | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPINCPeersSector |
|---|---|---|---|---|
P/E Ratio | 317.4x | 0.0x | −0.6x | |
PEG Ratio | −2.47 | 0.00 | 0.00 | |
Price/Book | 1.5x | 0.0x | 2.6x | |
Price / LTM Sales | 2.3x | 0.0x | 3.4x | |
Upside (Analyst Target) | 0.0% | 0.0% | 44.9% | |
Fair Value Upside | Unlock | 0.0% | 6.7% | Unlock |